Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review

被引:38
|
作者
Prevots, D. Rebecca [1 ]
Marshall, Julia E. [1 ]
Wagner, Dirk [2 ]
Morimoto, Kozo [3 ]
机构
[1] NIAID, Div Intramural Res, Epidemiol & Populat Studies Unit, NIH, 5601 Fishers Lane, Bethesda, MD 20852 USA
[2] Univ Freiburg, Fac Med, Med Ctr, Dept Internal Med 2,Div Infect Dis, Hugstetter St 55, b106, Freiburg, Germany
[3] Fukujuji Hosp, Japan AntiTB Assoc JATA, Div Clin Res, 3-1-24 Matsuyama, Tokyo, Japan
基金
美国国家卫生研究院;
关键词
Epidemiology; Nontuberculous mycobacteria; Mycobacterium avium; Mycobacterium abscessus; Pulmonary disease; Global; Exposome; ENVIRONMENTAL RISK-FACTORS; LUNG-DISEASE; CLINICAL-FEATURES; UNITED-STATES; PUBLIC-HEALTH; RESPIRATORY SPECIMENS; PREVALENCE; AVIUM; INFECTION; TUBERCULOSIS;
D O I
10.1016/j.ccm.2023.08.012
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
NTM-PD and NTM pulmonary isolation are increasing in most countries and regions globally. Isolate-based analysis in several countries indicates distinct trends by NTM species, highlighting the need for more species-specific analyses in NTM epidemiology. Available data regarding spe-cies indicates that MAC continues to predominate in most regions, although in Ontario, Canada, and distinct European countries M kansasii, M xenopi, and M malmoense are found with greater fre-quency. Variation in methods and case definitions limit comparisons across countries and regions. Population-based data including incidence and/ or prevalence are available from North America, Europe, East Asia (Japan, South Korea, and Taiwan), and Queensland, Australia. Studies from Central and South America, Africa, China, the Mid-dle East, and South Asia (India) among patients with suspected TB and MDR-TB are important to document the burden of undiagnosed NTM in this population and ensure appropriate treatment. This highlights the need for enhanced mycobacte-rial laboratory capacity to discriminate between cases of TB and NTM by routine speciation of mycobacterial isolates. Clinical data available from several regions have allowed better charac-terization of the affected populations. Across regions, the majority of cases occur among per -sons aged older than 50 years. In North America and East Asia, the proportion with COPD is typi-cally less than 20%, whereas in Europe, the pro-portion with COPD is higher, above 30% in 9 of 13 studies with this information. Implementation of surveillance systems with standard case definitions is needed to allow for global comparison of prevalence and trends. Cur-rent data where NTM-PD is a notifiable condition have shown the importance and utility of these surveillance data. In particular, timely notification data have allowed inference of the incubation period for infection and disease and have further allowed identification of specific high-risk environ-mental niches and environmental risk factors.
引用
收藏
页码:675 / 721
页数:47
相关论文
共 50 条
  • [31] Challenges of nontuberculous mycobacterial pulmonary disease in Mongolia
    Baigabyl, Bolyskhan
    Purevsuren, Yanjindulam
    Erkhembayar, Baasansuren
    Narmandakh, Erdenegerel
    Tumenbayar, Oyuntuya
    Burneebaatar, Buyankhishig
    Dashtseren, Ichinnorov
    RESPIROLOGY, 2023, 28 : 238 - 239
  • [32] Metabolomic Characteristics of Nontuberculous Mycobacterial Pulmonary Disease
    Kim, Jungeun
    Chae, Woori
    Kim, Joong-Yub
    Yim, Jae-Joon
    Cho, Joo-Youn
    Kwak, Nakwon
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (04): : 797 - 806
  • [33] Epidemiology of Nontuberculous Mycobacterial Lung Disease in US Veterans
    Miller, Donald
    Powell, William
    Zhang, Quanwu
    Garshick, Eric
    CHEST, 2017, 152 (04) : 126A - 126A
  • [34] Pathophysiology of pulmonary nontuberculous mycobacterial (NTM) disease
    Matsuyama, Masashi
    Matsumura, Sosuke
    Nonaka, Mizu
    Nakajima, Masayuki
    Sakai, Chio
    Arai, Naoki
    Ueda, Kodai
    Hizawa, Nobuyuki
    RESPIRATORY INVESTIGATION, 2023, 61 (02) : 135 - 148
  • [35] Host Susceptibility to Nontuberculous Mycobacterial Pulmonary Disease
    Namkoong, Ho
    Holland, Steven M.
    CLINICS IN CHEST MEDICINE, 2023, 44 (04) : 723 - 730
  • [36] Cure rates in nontuberculous mycobacterial pulmonary disease
    Makek, Mateja Jankovic
    Glodic, Goran
    Sabol, Ivan
    Zmak, Ljiljana
    Sola, Ana-Marija
    Marusic, Ante
    Marekovic, Ivana
    Hecimovic, Ana
    Dugac, Andrea Vukic
    Dzubur, Fedja
    Jakopovic, Marko
    Ticac, Brigita
    Bulat, Ljiljana Kardum
    Grle, Sanja Popovic
    Barisic, Blazenka
    Vladic, Vesna Carevic
    Strelec, Drazen
    Pavlisa, Gordana
    Samarzija, Miroslav
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [38] Familial Clustering of Pulmonary Nontuberculous Mycobacterial Disease
    Colombo, Rhonda E.
    Hill, Suvimol C.
    Claypool, Reginald J.
    Holland, Steven M.
    Olivier, Kenneth N.
    CHEST, 2010, 137 (03) : 629 - 634
  • [39] Beyond antibiotics for pulmonary nontuberculous mycobacterial disease
    Waterer, Grant
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (03) : 260 - 266
  • [40] Nontuberculous mycobacterial pulmonary disease in an immunocompetent adolescent
    Wong, Kin-Sun
    Lin, Tzou-Yien
    Huang, Yhu-Chering
    Chin, Chih-Yung
    RESPIRATORY CARE, 2008, 53 (07) : 908 - 911